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Selected Abbreviations and Acronyms 
AVD: atherovascular disease 
CKD: Chronic kidney disease  
FMD: flow mediated dilation 
Hb: haemoglobin  
HDL: high density lipoprotein  
ICAM- 1: intracellular adhesion molecule 1 
IL-6: interleukin 6 
IMT:  intima-media thickness 
LP (a): lipoprotein (a) 
Ns: not significant 
PDRF: predialysis renal failure 
PTH: parathyroid hormone 
s-CRP: sensitive C-reactive protein  
TG: triglycerides  
TNF-α: tumour necrosis factor alpha 
U- albumin flow: urine albumin flow  












Background: Chronic kidney disease (CKD) is a major risk factor for developing 
atherosclerotic vascular disease (AVD), which plays a major role in causing morbidity and 
mortality in these patients.   
Objectives: The aim of this study was to investigate endothelial dysfunction, subclinical 
atherosclerosis and inflammatory activity in patients with CKD stages 3-4 compared to a 
population-based control group.   
Design: The study groups consisted of 35 controls and 50 predialytic renal failure (PDRF) 
patients. Flow- mediated dilatation (FMD) and intima-media thickness (IMT) in the brachial 
artery was measured by B-mode high-resolution ultrasound. 
Setting: University hospital. 
Results: IMT was significantly increased in the PDRF patients compared to the controls 
(0.43±0.06 vs. 0.34±0.05; p<0.001). However there was no significant difference in FMD 
between the study groups (0.047 ± 0.04 vs. 0.053 ± 0.05; p:Ns). VCAM-1, ICAM-1 and TNF- 
α were higher in the PDRF group compared to the control group (p< 0.05). IMT was 
significantly associated (p< 0.05) with haemoglobin, creatinine, phosphate and IL-6 in the 
PDRF group and FMD was significantly (p< 0.05) negatively associated with fibrinogen, 
TNF- α and IL-6 and positively associated with triglyceride levels in the PDRF group.  
Conclusion: PDRF patients have increased IMT, fibrinogen and inflammatory activity 
compared to the control group. IL-6 was associated with an increased IMT and a poorer 
endothelial function.   
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Cardiovascular mortality and morbidity is significantly increased among patients with chronic 
kidney disease (CKD). It is estimated that the risk of atherosclerotic vascular disease (AVD) 
in this group is 10-20-fold higher than in the general population [1-3]. Studies have reported 
an impairment of endothelium dilatation in CKD patients [4-6]. The endothelium has an 
important role in the initiation of atherosclerosis. By damage to the endothelial wall, the nitric 
oxide (NO) production decreases, and consequently the endothelium- dependent 
vasodilatation is impaired. This is an early key event in atherogenesis [7, 8]. Atherosclerosis 
is an inflammatory process, and atherogenic factors such as hypertension, hyperlipidemia and 
hyperglycemia are among the major variables, which can lead to endothelial dysfunction, 
which again is manifested by overproduction of selective adhesion molecules such as vascular 
cellular adhesion molecule (VCAM- 1), and intracellular adhesion molecule (ICAM- 1). 
These factors facilitate leukocyte and monocyte adhesion. Monocytes transform into 
macrophages and phagocytose oxidized LDLs. Consequently foam cells arise which attract 
cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). These activate 
and recruit inflammatory cells. In addition IL-6 stimulates synthesis of acute phase proteins 
by the liver, especially CRP and fibrinogen [9]. High levels of acute- phase proteins have 
been recognized as a leading associated factor with mortality in renal failure patient 
populations [10]. It is possible to measure serum levels of inflammatory markers to detect an 
inflammation process. By using an ultrasonographic method, it is possible to measure flow 
mediated dilatation (FMD) and intima- media thickness (IMT) to detect endothelial 
dysfunction and asymptomatic atherosclerosis [11-13]. 
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Our goal was to compare the endothelial functional and subclinical atherosclerosis in 
predialytic renal failure disease (PDRF) patients and control subjects, and to consider whether 
there exist a relationship between serum inflammatory markers and asymptomatic 




All subjects gave informed consent after written and oral information. The ethics committee 
of the Karolinska
 
University Hospital Huddinge (Stockholm, Sweden) approved the study. 
PDRF patients were recruited from the renal outpatient clinic Karolinska University 
Hospital.PDRF patients (42 men; age 59 ± 14 yr [range 27 to 80 yr])
 
with stages 3 to 4 CKD 




15 to 52 ml/min per 1.73 m
2
). Exclusion criteria 
for the present study were, in addition to unwillingness/inability to participate in the study 
procedures, clinical signs of acute
 




The causes of CKD were chronic glomerulonephritis in 13 (26 %)
 
patients, 
diabetic nephropathy in 7 (14 %) patients, polycystic
 
kidney disease in 3 (6 %) patients, 
interstitial nephritis
 
in 2 (4 %) patients, nephrosclerosis in 10 (20 %) patients, and
 
other or 
unknown in 15 (30 %) patients. 
Presence of clinical
 
CVD was defined by medical history and clinical symptoms and/or
 
findings of cardiac, cerebrovascular (stroke), and/or peripheral
 
vascular disease. A total of 14 
(28 %) patients had a clinical
 
history or signs of cardiovascular, cerebrovascular, and/or
 
peripheral vascular disease at the start of the study. Most
 
patients were on antihypertensive 
medications as well as other
 
commonly used drugs in patients with CKD, such as phosphate
 
and potassium binders; diuretics; erythropoiesis-stimulating
 
agents; iron substitution; lipid-
lowering medication; and vitamins
 




A population-based randomly selected group of 35 control subjects
 
(25 men; age 62 ± 13 yr 
[range 29 to 81 yr] were used
 
for comparative analyses of biochemical and metabolic 
parameters.
 
The control group comprised
 




to an invitation sent to randomly selected individuals
 
in the Stockholm 
region by Statistics Sweden. The control subjects
 
were investigated according to a similar 
protocol and simultaneously
 
as the patients. No other exclusion criteria than unwillingness
 
to 
participate in the study were applied in the selection of
 
the healthy controls. 
Measurements 
After an overnight fast, venous blood samples were drawn and
 
stored at –80°C for 




concentrations were measured by using commercially available
 
ELISA kits (R&D System, 
Minneapolis, MN). The serum levels
 
of IL-6 and TNF-alfa were quantified on an Immulite 
automatic analyzer
 
(Diagnostic Products Corp., Los Angeles, CA). Serum cholesterol
 
and 
triglyceride levels were analyzed by means of standard enzymatic
 
procedures (Roche 
Diagnostics, Mannheim, Germany). HDL cholesterol
 
level was determined after precipitation 
of apolipoprotein B–containing lipoproteins by using phosphotungstic acid. Serum albumin 
(bromcresol
 
purple method), hs-CRP, creatinine, urea, and hemoglobin and urinary
 
creatinine 
and urea were determined by routine procedures at
 
the Department of Clinical Chemistry, 
Karolinska University
 






Assessment of FMD and IMT in brachial artery   
 The ultrasound procedures for assessing endothelium-dependent FMD were performed as 
described in the international guidelines by Corretti et al. (14). The subjects were examined in 
the morning after an overnight fast. They were told not to use long-acting nitroglycerin or 
calcium channel blocking drugs 36 hours before the examination. A high-resolution 
ultrasound scanner (System Five, GE Vingmed, Horten, Norway) with a 10.0-MHz linear 
array transducer was used. After 10-minute equilibration period at rest in the recumbent 
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position, a single dedicated ultrasonographer performed measurements of the left brachial 
artery FMD proximal to the antecubital fossa. The scans were saved on videotape. Baseline 
diameter recordings were obtained after which arterial occlusion was performed by inflating a 
forearm blood pressure cuff (12, 5 cm wide) to 250 mmHg for 4.5 min. After cuff-release, 
diameter recordings were repeated during the post-occlusive increase in brachial artery blood 
flow. The complete experimental sequence was performed twice at 30 minutes intervals. 
Images were digitally acquired from the videotape and measured in random order by a single 
observer blinded to the conditions under which the ultrasonographic images were obtained. 
Measurement of the brachial artery diameter was defined as the distance from the leading 
edge of the near wall intima-lumen echo to the leading edge of the far wall lumen-intima echo 
along a line perpendicular to the artery’s long axis. A computer system (15) with automated 
tracing of echo interfaces and measurements of distances between the wall echoes within a 5 
mm long section of the brachial artery was used. Brachial artery diameter was calculated in 
diastolic frames taken coincidentally with the R wave on the electrocardiogram twice at rest 
and then 45, 60 and 75 seconds after cuff deflation. Mean of the diameters after 45, 60 and 75 
seconds was calculated. Diameter changes were expressed as the percentage change relative 
to the mean baseline value. The mean of two FMD examinations was used. The intima-media 
thickness of the brachial artery was defined as the distance between the leading edge of the 
lumen-intima echo and the leading edge of the media-adventitia echo in the far wall. The 
lumen diameter was defined as the distance between the leading edge of the intima-lumen 
echo of the near wall and the leading edge of the lumen-intima echo of the far wall.  The 
differences between repeated measurements of intima-media thickness, lumen diameter and 
FMD, by using the automated analysing system, were 3.0 %, 1.4 % and 5.5 % (coefficient of 




All data are presented as mean ± SD or percentage (%). Unpaired student t-test was used to 
analyze differences among the study groups. Nonparametric Spearman’s rank correlation test 









Table 1 shows the demographic characteristics of the PDRF patients and controls. There were 
no differences with respect to gender, age, troponin T and I, cholesterol, Apo A, Apo B, LP 
(a), U- albumin flow, arginin or glucose in these two groups. However, the PDRF patients 
were significantly heavier and taller. Moreover, they had lower Hb ( p<0,001), higher urea ( 
p<0,001), higher creatinine (p<0,001), lower albumin (p<0,001),  higher Ca
2+
 (p< 0,001), 
higher phosphate (p=0,001), higher PTH (p<0,001), higher fibrinogen (p<0,001), lower HDL-
choleaterol (p<0,001), higher TG (p<0,001) and lower iohexolclearance (p<0,001) compared 
to the control group (table 1). As expected due to the fact that they had kidney failure, the 
PDRF patients differed from the control group with respect to several parameters as shown in 
table 1. 
 
As it is presented in Table 2, PDRF patients have significantly higher VCAM-1(p=0,00), 
ICAM-1(p=0,04) and TNF-α(p=0,00) than controls. However s- CRP and IL-6 were not 
significantly increased in the patient group compared to the controls. 
 
Differences in FMD and IMT in the brachial artery between PDRF patients and controls are 
illustrated in Fig.1. IMT in PDRF patients was significantly higher than in controls (0.43±0.06 
vs. 0.34±0.05; p<0.001). FMD was not significantly higher among controls compared to 
PDRF (0,053±0,05 vs. 0.047±0,04;p:Ns, Figure 1). 
 
In patients with PDRF, significant relationships between IMT and Hb (p=0.04), creatinine 
(p=0.04) and phosphate (p=0.04) were found. FMD was positively associated with 
TG(p=0,01) and negatively with fibrinogen(p=0.04).  In addition IMT was significantly 
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associated with IL-6 (p=0.01). FMD was negatively associated with TNF-α (p=0.04) and IL-
6(p=0.04),(Table 3).   
 
Discussion 
High-resolution B- mode ultrasonography is a non-invasive, safe and reproducible method to 
detect endothelial dysfunction by measuring variables such as FMD and IMT, and 
consequently investigate preclinical atherosclerosis [7, 16-19]. Individuals with impaired 
endothelial function and thickened IMT carry a major risk for future CVD.  Since 
cardiovascular death rate is much higher among dialysis patients than healthy individuals, 
CKD is defined as a pro-atherogenic state [20]. The endothelium dependent dilatation is 
abnormal in CKD patients with asymptomatic vascular disease, and it is suggested that the 
impaired endothelial function precedes the development of CVD in uremic patients [21]. 
However, it is unclear during which phase of the disease progression towards dialysis these 
changes occur. In the present study we have investigated these variables in patients with 
predialytic RF. 
 
Some other investigators have also reported an impaired FMD in asymptomatic children and 
young adults with established risk factors for atherovascular disease [7]. These trials make the 
FMD a valuable variable to detect early AVD. We found a slightly higher FMD in the control 
group compared to the PDRF; however the difference was not significant. The explanation to 
this conflicting result could be that FMD is influenced by confounding factors such as age 
[22]. FMD normally decreases with age and therefore one might find no difference in FMD 
when comparing a diseased group with a healthy group when the subjects are over 60 years 
old. However, another study, which examined CKD patients with approximately the same age 
as in our study, observed a significantly impaired FMD among the patients [21]. We observed 
 12 
a similar tendency and the discrepancy might be explained by a type II error in the present 
study due to underpowering of the study with respect to FMD. This is supported by the wide 
confidence intervals of the FMD estimates.  On contrary the present study showed that IMT is 
significantly different between the controls and PDRF group.  
 
Previous studies have demonstrated that classical risk factors for CVD are significantly 
correlated with FMD% [23]. On the other hand there are other studies suggesting that FMD% 
is also correlated to the non-traditional risk factors for developing AVD in CKD patients [24]. 
We found a positive association between TG and FMD, but no associations between FMD 
and cholesterol and glucose were observed. The present study showed a significant correlation 
between Hb, creatinine and phosphate and IMT. At the same time no correlations between 
TG, cholesterol and glucose and IMT were found. These results suggest that IMT impairment 
in CKD patients is associated not only with the traditional risk factors for AVD. This 
suggestion is in line with other studies which reported that IMT is not only associated with the 
classical risk for CVD, but also the untraditional ones [24]. 
 
We found no significant correlation between IMT and FMD. This result is also reported in a 
previous study, which suggested that there is not any association between FMD and IMT in 
predialysis patients [24]. The authors suggested that FMD and IMT examine different aspects 
and stages of atherosclerosis. We have previously reported a linear relationship between IMT 
in the brachial artery and coronary artery disease, as well as a significant correlation between 
IMT in the brachial artery and carotis IMT, in a group of patients with severe coronary artery 
disease [22]. These findings underline that brachial artery IMT can be used to detect AVD in 
a preclinical phase. However, despite a significant correlation between IMT in the brachial 
artery and coronary artery disease and carotid IMT, it cannot be excluded that increased IMT 
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in the brachial artery represents muscular medial thickening rather than intimal thickening 
[22]. 
It is well known that the inflammatory activity is increased in patients with dialysis [9].  In 
this study of PDRF patients we observed increased inflammatory activity in the PDRF group 
compared to the control group. VCAM, ICAM and TNF-α were significantly elevated in the 
PDRF group whereas the elevations of CRP and IL-6 did not reach significance levels. Thus, 
the increased inflammatory activity seems to be present even before the disease progresses to 
dialysis. 
 
Atherosclerosis is an inflammatory disease. We described that increased IL-6 was 
significantly associated with both IMT and FMD in the PDRF group. The correlations 
between VCAM-1, ICAM-1 and FMD and IMT did not reach the significance level. A 
previous study has found that VCAM-1 and IL-2 receptor correlates with IMT in 
haemodialysis patients [9]. In another study a significant association between ICAM-1 and 
IMT was found in patients on continuous ambulatory peritoneal dialysis, however they failed 
to show any correlation between IMT and VCAM-1 [25].   
 
In summary we have shown that brachial IMT is significantly increased in PDRF patients, and 
it correlates with Hb-, creatinine- and phosphate levels. This proposes that this patient 
category carry a major risk for developing AVD during the progression of their renal disease, 
and it might be explained by a combination of the traditional risk factors and some additional 
coexisting factors. The PDRF group had an increased inflammatory activity, and a positive 
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Table 1: Demographic, haemodynamic and biochemical parameters. 
Parameters PDRF (N=50) Controls (N=35) p-value 
Gender(male/female) 42/8 25/10 Ns 
Age(years) 59±14,6 62±12,9 Ns 
Weight (Kg) 82±15 75±11 0.01 
Length (Cm) 177±8.8 172±7.9 0.03 
Body mass index (kg/m2) 27±4 25±3 0.05 
Hb(g/dl) 126±14.6 1418.2 0.00 
Systolic blood pressure (mm Hg)  156±22  139±22  0.001 
Diastolic blood pressure (mm Hg)  92±11  88±10  0.03 
Cholesterol(mmol/L) 5.2±1.2 5.1±0.80 Ns 
HDL-cholesterol(mg/L) 1.2±0.4 1.5±0.3 0.00 
Apo A-1(g/L) 1.4±0.2 1.5±0.2 Ns 
Apo B-1(g/L) 1.1±0.3 0.95±0.2 Ns 
TG(mmol/L) 2.3±1.27 1.2±0.5 0.00 
LP (a)(mg/L) 248±287 216±251 Ns 
S-Creatinine(µmol/L) 300±147 80±17 0,00 
S-Albumin(g/L) 37±3.3 39±2.3 0.00 
S-Ca2+(mmol/L) 2.4±0.1 2.3±0.1 0.00 
S-Phosphate(mmol/L) 1.4±0.4 1.0±0.2 0.00 
PTH 123±82 40±16 0.00 
Urea(mmol/L) 19±6.5 5.7±1.3 0.00 
U-albumin (mg/24 h) 1215±1351 59±54 0.00 
Iohexolclearance (ml/min*1.73 m2) 27±10 88±14 0.00 
Arginin 79±18.6 81±20.9 Ns 
Fibrinogen(mmol/L) 3.8±0.8 2.9±0.6 0.00 
Glucose(mmol/L) 6.0±1.8 6.4±7.0 Ns 
Troponin T (ug/l) 0.02±0.03 0.01±0.01 Ns 
Troponin I  (ug/l) 0.01±0.02 0.02±0.05 Ns 
 
Data are expressed as mean ±standard deviation (SD) or percentage (%). 
Hb: haemoglobin, PTH: parathyroid hormone, HDL: high-density lipoprotein, TG: 
triglycerides, LP (a): lipoprotein (a), U- albumin flow: urine albumin flow, Ns: not significant, 












Table 2: Serum levels of inflammatory markers in CKD patients and controls. 
Parameters PDRF (N=50) Control (N=35)                                  p-value 
s- CRP (mg/L) 5.0±7.6 2.7±5.6 Ns 
VCAM- 1 (ng/mL) 984±282 722±162 <0.001 
ICAM- 1 (ng/mL) 253±47.8 232±47.1 0.04 
TNF-α (pg/mL) 9.1±4.3 4.3±2.1 <0.001 
IL-6 (pg/mL) 2.8±1.2 2.0±2.1 Ns 
 
Data are expressed as mean ±standard deviation (SD) or percentage (%).         
s-CRP: sensitive C-reactive protein, VCAM-1: vascular cellular adhesion molecule 1, ICAM- 




Table 3: Correlations of IMT and FMD in the brachial artery and the inflammatory 










s-CRP(mg/dL) 0.18 Ns -0.11 Ns 
VCAM- 1(ng/mL) 0.13 Ns -0.20 Ns 
ICAM- 1(ng/mL) -0.18 Ns 0.17 Ns 
TNF-α (pg/mL) 0.14 Ns -0.31 0.04* 




s-CRP: sensitive C-reactive protein, VCAM-1: vascular cellular adhesion molecule 1, ICAM- 
1: intracellular adhesion molecule 1, TNF-α: tumour necrosis factor alpha, IL-6: interleukin 6. 





















































Figure 1: Comparison of flow- mediated dilatation (FMD), and intima- media thickness 
(IMT) between predialysis renal failure (PDRF) patients and controls. 
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